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When susceptibility to diseases is caused by cis-effects of multiple alleles at adjacent poly-
morphic sites, it may be difﬁcult to assess with conﬁdence the genetic phase and identify
individuals carrying the risk haplotype. Experimental assessment of genetic phase is still
challenging andmost population studies use statistical approaches to infer haplotypes given
the observed genotypes. While these statistical approaches are powerful and have been
proven very useful in large scale genetic population studies, they may be prone to errors
in studies with small sample size, especially in the presence of compound heterozygotes.
Here, we describe a simple and novel approach using the popular PCR–RFLP based strat-
egy to assess the genetic phase in compound heterozygotes.We apply this method to two
extensively studied SNPs in two clustered immune-related genes: The −308 (G>A) and
the +252 (A>G) SNPs of the tumor necrosis factor (TNF ) alpha and the lymphotoxin alpha
(LTA) genes, respectively. Using this method, we successfully determined the genetic
phase of these two SNPs in known compound heterozygous individuals and in every sam-
ple tested.We show that the A allele ofTNF −308 is carried on the same chromosome as
the LTA 252(G) allele.+
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INTRODUCTION
SNPs are useful in mapping disease susceptibility genes. However,
the SNPs identiﬁed from typical genetic mapping studies often are
not the causal SNPs but may tag the true causal mutation if they
are in linkage disequilibrium with each other (Ardlie et al., 2002;
Gabriel et al., 2002; Ke et al., 2004). To increase heterozygosity,
genetic information, and statistical power, haplotypes are usually
reconstructed from observed genotypes to identify the individu-
als carrying the risk haplotypes. Haplotypes are also valuable for
exploring cis-effects of speciﬁc combinations of intragenic poly-
morphisms, such as those variations located in gene promoters, or
polymorphisms in closely linked genes where there may be inter-
action that affects gene expression (Levenstien et al., 2006; Fan
et al., 2011).
Statistical and computationalmethods canprovidehighly accu-
rate estimates of haplotypes reconstructed from conventional
genotype data in most situations, but even the best method can
have a large error rate ofmore than35%fordatasetswhere parental
genotypes are unknown (Stephens and Donnelly, 2003; Marchini
et al., 2006; Browning, 2008; Liu et al., 2008). Several experimental
methods for haplotype and genetic phase determination have been
reported, including cloning (Burgtorf et al., 2003; Kitzman et al.,
2011), hybridization (Yan et al., 2000; Douglas et al., 2001; Boldt
and Petzl-Erler, 2002), polony technology (Mitra et al., 2003),
MALDI-TOF mass spectrometry (Tost et al., 2002), sequencing
(Levy et al., 2007), and chromosome micro-dissection (Ma et al.,
2010). However, these methods are labor-intensive and/or require
specialized and expensive equipment. PCR-based methods, such
as allele-speciﬁc PCR and isolation of single DNA molecules have
been used in the past to determine haplotypes and genetic phase
(Ruano et al., 1990; Michalatos-Beloin et al., 1996; Zhang et al.,
2006), but experimental optimization is needed and/or is labor-
intensive. All of the above methods may not be applicable in
settings where cost is a premium and specialized equipment is not
available or personnel have little or no training in labor-intensive
methodologies.
We present here a simple application of the popular PCR–RFLP
based strategy to determine the genetic phase at two adjacent SNPs
in compound heterozygous individuals. Speciﬁcally, we looked
at rs909253 (A>G) at position +252 of the lymphotoxin alpha
(LTA) gene and about 3 kb downstream, rs1800629 (G>A), at
position −308 of the tumor necrosis factor (TNF) alpha gene
in the major histocompatibility complex. Using this method, we
determined the phase of these two SNPs in nine individuals shown
in a previous study to be heterozygous both at the LTA +252 and
the TNF −308 positions (Aissani et al., 2009).
MATERIALS AND METHODS
DNA was extracted from peripheral blood mononuclear cells
(Qiagen, Valencia, CA, USA) obtained from nine subjects who
were double heterozygotes for the LTA +252 and TNF −308
SNPs (Aissani et al., 2009). Human subject approval was given
by the Institutional Review Board at UAB and informed consent
was obtained from all subjects. DNA quantitation was deter-
mined by a ﬂuorometric method using the Qubit™ﬂuorome-
ter (Invitrogen, Carlsbad, CA, USA). For the ﬁrst PCR, 50 ng
of DNA from each subject were used to amplify the 3.4-kb
fragment separating the LTA and TNF SNPs. Due to the large
size of the fragment to be ampliﬁed and its high GC content
(75%), we used the Qiagen LongRange PCR kit. All primers
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were designed using Primer 3 (http://frodo.wi.mit.edu/primer3/).
A ﬁnal concentration of 0.4μM of primers L–T for-
ward (5′-GCTTCGTGCTTTGGACTACC-3′) and reverse (5′-
GTCCTTTCCAGGGGAGAGAG-3′) were added to a 25-μl reac-
tion containing 2.5mM Mg++, 500μM of each dNTP, 1× Q-
solution, and two units of enzyme. DNA ampliﬁcation was per-
formed at an initial denaturation at 95˚C for 3min followed by
35 cycles of denaturation at 95˚C/30 s, annealing at 62˚C/30 s, and
extension at 68˚C for 3min. After product speciﬁcity was tested
and conﬁrmed by agarose gel electrophoresis, the products were
puriﬁed using the Qiagen PCR puriﬁcation kit. Approximately
5μl of 25μl puriﬁed product were digested with two and one-
half units of NcoI restriction endonuclease enzyme (NEB, Ipswich,
MA, USA) in a total reaction of 25μl for 1 h at 37˚C. The digested
and undigested samples were run in adjacent lanes along with a
1-kb size standard (Fermentas, Glen Burnie,MD, USA) on a 1.2%
agarose gel. The samples were run ﬁrst for 16 h at 20V constant
overnight and then 40V for 7 h in order to obtain sufﬁcient separa-
tion of the fragments for removal from the gel. The gel was stained
with ethidium bromide for 30min, followed by destaining in 1×
TBE for 10min. Under low UV light, the shorter 3.2 kb digested
NcoI fragment containing the G allele at LTA +252 was identiﬁed
and sliced from the gel.
The DNA fragment was eluted from the gel slice using
the QIAquick Gel Extraction Kit. For the second PCR, TNF
forward (5′-GCCCCTCCCAGTTCTAGTTC-3′) and reverse (5′-
TTGGAAAGTTGGGGACACAC-3′) primers were designed to
ﬂank the TNF −308 site. We generated a 248-bp PCR fragment
from 1μl of gel puriﬁed product in a 20-μl reaction contain-
ing 0.5μM each of primers and standard PCR reagents (200μM
dNTPs, 1.5mMMg++, and one unit of Amplitaq; Applied Biosys-
tems, Foster City, CA, USA). After an initial denaturation at 95˚C
for 3min, 35 cycles of denaturation at 95˚C/30 s, annealing at
56˚C/30 s, and extension at 72˚C/30 s were performed, followed
by a ﬁnal extension of 72˚C for 5min. The PCR product was puri-
ﬁed through silica columns (Qiagen,Valencia,CA,USA) to remove
dNTPs and non-incorporated primers. To identify the allele at the
TNF −308 site, the nucleotide sequence of the puriﬁed 248 bp
fragment was determined by Big Dye terminator cycle sequencing
on a 3730 Genomic Analyzer (Applied Biosystems, Forrest City,
CA, USA) using the TNF reverse primer.
RESULTS
Figure 1 shows the locations of the LTA +252 andTNF −308 SNPs
in the initial 3.4 kb PCR product and in the resulting 3.2 kb NcoI
digested fragment when the “G” allele is present at the LTA +252
site. Since each of the nine samples was heterozygous for the LTA
+252 SNP (A>G), digestion of the PCR product with NcoI gen-
erated DNA fragments of 3.4 and of 3.2 kb of length carrying the
“A” and the “G” alleles, respectively (Figure 2). Because allele “G”
of LTA +252 can occur with either “A” or “G” allele of TNF −308,
genetic phase was determined by sequencing the 3′ end of the 3.2-
kb NcoI fragment that encompasses the TNF −308 site. Figure 3
shows the DNA sequences surrounding the TNF −308 site in the
nine tested samples. As can be seen, all nine samples carry theTNF
−308 “A” allele (displayed as the “T” allele on the reverse strand).
Therefore, all nine subjects who had the“G”allele at the LTA +252
FIGURE 1 | Location of LTA +252 andTNF −308 SNPs in PCR product
and NcoI fragment.
FIGURE 2 | Gel separation of digested and undigested NcoI fragments.
Lane 1: 1 kb size std.; Lane 2: NcoI digest of PCR from subject 1; Lane 3:
ﬁrst PCR product from subject 1.
site possess the “A” allele at the TNF −308 site. Since all nine indi-
viduals are known compound heterozygotes (Aissani et al., 2009),
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FIGURE 3 | Sample sequences ofTNF −308 SNP on NcoI digested fragment (3′strand). “T” nucleotide on the 3′ strand represents theTNF −308 “A” allele
on 5′ strand.
the phase on the other chromosomemust be LTA +252 (A) –TNF
−308 (G).
DISCUSSION
For population studies where often hundreds or thousands of
individuals are sampled, phase determination can usually be sta-
tistically inferred, i.e., probabilistically. Family data can also assist
in determining phase. However, if only a few subjects are geno-
typed, determining phase usually must rely on laborious methods
such as puriﬁcation of singlemolecules to isolate the alleles. Allele-
speciﬁc PCR is relatively simple but is limited by the demand of
allele-speciﬁc oligoswhichmay not always be compatible with efﬁ-
cient ampliﬁcation. The PCR–RFLP technique we present here is
a simple, cost–effective way to determine phase when compound
heterozygotes are present, especially in studies of small sample
size or when family data are not available. This method does not
require expensive equipment and can be performed with the basic
tools found in most laboratories with only moderate technical
experience. There are a couple of factors that can affect or even
restrict the use of this technique. If one of the SNPs is not a
restriction site, allele-speciﬁc PCR could be utilized as an alter-
native. However, our method is more ﬂexible than allele-speciﬁc
PCR as any heterozygous site upstream of the SNP sites of interest
could be used to generate fragments with different electrophoretic
mobilities, although sequencing across both SNPs on the shorter
fragment would be necessary. Here, there was no need to sequence
through the LTA +252 site because the allele was determined by
RFLP. Size is an obvious limitation of the technique we present
here since a template of ∼40 kb approaches the upper limit for
successful ampliﬁcation. Finally, some initial optimization of PCR
and electrophoretic conditions, such as the presence of difﬁcult
sequences (e.g., GC content) and similarly sized cut and uncut
fragments, may be necessary.
We present here a simple, cost–effective method for determin-
ing genetic phase between SNPs in compound heterozygotes. We
were able to use this PCR–RFLP procedure to determine phase for
two SNPs that are 3 kb apart in nine such individuals. Speciﬁcally,
using this procedure, we show that allele A of TNF −308 is in
complete disequilibrium with allele G of LTA +252. This proce-
dure would be very helpful for diseases or conditions where the
clinical manifestation and/or outcome are associated with haplo-
types. Except for sequencing,which can be outsourced to relatively
inexpensive sequencing services, this procedure can be performed
in most labs with only moderate technical experience and with no
expensive equipment or high up-front cost. This technique could
eventually be applied in clinical settings where disease susceptibil-
ity or variability in expression is anurgent need.Although there are
certain situations that can limit the practical use of this approach,
the simple design, and relatively inexpensive cost makes it a viable
alternative to current methods.
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